Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:40 AM
Ignite Modification Date:
2025-12-25 @ 2:40 AM
NCT ID:
NCT02618733
Eligibility Criteria:
Inclusion Criteria:
* Provision of informed consent prior to any study specific procedures
* All patients with ACS scheduled for PCI will be eligible, assuming their ability to understand the character and individual consequences of participation as well as giving written informed consent.
* Be able to understand and comply with the requirements of the study, as judged by the investigator.
Exclusion Criteria:
* History of intracranial bleeding
* Severe hepatic impairment
* Active pathologic bleeding
* Hypersensitivity to ticagrelor or any of the excipients
* Liver cirrhosis greater than or equal to Child class B
* Decreased serum platelet level (≤ 100,000/uL)
* Life expectancy ≤ 1 year
* Need for chronic oral anticoagulant therapy
* Patients with known bleeding diathesis or coagulation disorder
* History of previous intracranial bleed at any time, gastrointestinal bleed within the past 6 months, or major surgery within 30 days.
* Ischemic stroke within the previous 14 days
* Renal failure requiring dialysis or anticipated need for dialysis during the course of the study
* Concern for inability of the patient to comply with study procedures and/or follow up
* Unable to give informed consent.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
85 Years
Study:
NCT02618733
Study Brief:
Protocol Section:
NCT02618733